Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14036 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Matteo Rinaldi und 32 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, IRCCS Sant'Orsola Hospital, Bologna, Italy. Hauptthemen laut MEDLINE: Organ Transplantation, Liver Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Management of infections due to carbapenemase‐resistant Enterobacterales (CRE) in solid organ transplant (SOT) recipients remains a difficult challenge. The INCREMENT‐SOT‐CPE score has been specifically developed from SOT recipients to stratify mortality risk, but an external validation is lacking.
Methods
Multicenter retrospective cohort study of liver transplant (LT) recipients colonized with CRE infection who developed infection after transplant over 7‐year period. Primary endpoint was all‐cause 30‐day mortality from infection onset. A comparison between INCREMENT‐SOT‐CPE and other selected scores was performed. A two‐level mixed effects logistic regression model with random effects for the center was fitted. Performance characteristics at optimal cut‐point were calculated. Multivariable Cox regression analysis of risk factors for all‐cause 30‐day mortality was carried out.
Results
Overall, 250 CRE carriers developed infection after LT and were analyzed. The median age was 55 years (interquartile range [IQR]: 46–62) and 157 were males (62.8%). All‐cause 30‐day mortality was 35.6%. A sequential organ failure assessment (SOFA) score ≥ 11 showed a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of 69.7%, 76.4%, 62.0%, 82.0%, and 74.0%, respectively. An INCREMENT‐SOT‐CPE ≥ 11 reported a sensitivity, specificity, PPV, NPV, and accuracy of 73.0%, 62.1%, 51.6%, 80.6% and 66.0%, respectively. At multivariable analysis acute renal failure, prolonged mechanical ventilation, INCREMENT‐SOT‐CPE score ≥ 11 and SOFA score ≥ 11 were independently associated with all‐cause 30‐day mortality, while a tigecycline‐based targeted regimen was found to be protective.
Conclusions
Both INCREMENT‐SOT‐CPE ≥ 11 and SOFA ≥ 11 were identified as strong predictors of all‐cause 30‐day mortality in a large cohort of CRE carriers developing infection after LT. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, IRCCS Sant'Orsola Hospital, Bologna, Italy.
- Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- Working Committee for Hospital Epidemiology and Infection Control, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
- Infectious Diseases Department, Hospital das Clinicas, Universidade de São Paulo, São Paulo, Brazil.
- Department of Surgical Sciences, Liver Transplant Center, General Surgery Unit, AOU Città della Salute e della Scienza, Molinette Hospital, University of Turin, Turin, Italy.
- University Infectious Diseases, University of Turin, Turin, Piemonte, Italy.
ORCID-Profile: Matteo Rinaldi, Maristela Freire, Alessandra Mularoni, Jacques Simkins, Lilian Abbo, Maricela Valerio, Patricia Muñoz, Dafna Yahav, Maddalena Giannella
Zitieren
APA
Rinaldi, M., Bonazzetti, C., Gallo, M., Ferraro, G., Freire, M., Terrabuio, D. R. B., Tandoi, F., Romagnoli, R., De Rosa, F. G., Mularoni, A., Ferrarese, A., Burra, P., Halpern, M., Balbi, E., Simkins, J., Abbo, L., Morrás, I., Cantero, M., Alagna, L., …, & CRECOOLT study group (2023). Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection. Transplant Infectious Disease. https://doi.org/10.1111/tid.14036
Vancouver
Rinaldi M, Bonazzetti C, Gallo M, Ferraro G, Freire M, Terrabuio DRB, et al. Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection. Transplant Infectious Disease. 2023. doi:10.1111/tid.14036
BibTeX
@article{Rinaldi2023,
author = {Rinaldi, Matteo and Bonazzetti, Cecilia and Gallo, Mena and Ferraro, Giuseppe and Freire, Maristela and Terrabuio, Débora Raquel Benedita and Tandoi, Francesco and Romagnoli, Renato and De Rosa, Francesco Giuseppe and Mularoni, Alessandra and Ferrarese, Alberto and Burra, Patrizia and Halpern, Marcia and Balbi, Elizabeth and Simkins, Jacques and Abbo, Lilian and Morrás, Ignacio and Cantero, Mireia and Alagna, Laura and Bandera, Alessandra and Clemente, Wanessa Trinidade and Valerio, Maricela and Fernández, Ainhoa and Muñoz, Patricia and Statlender, Liran and Yahav, Dafna and Camargo, Luis Fernando Aranha and Girão, Evelyne Santana and Grossi, Paolo and Viale, Pierluigi and Curti, Stefania and Giannella, Maddalena and CRECOOLT study group, CRECOOLT study group},
title = {Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14036}
}
EUVIMED